EUVIMEDEUVIMED entdecken
Crossref

Bisbenzylisoquinoline Alkaloids From Genus Triclisia As Potential Anticancer Agents: A Review

Fidelis Nekesa Samita

IOSR Journal of Applied Chemistry · 2026-04 · 19 (4) · 18-27

DOI: 10.9790/5736-1904011827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IOSR Journal of Applied Chemistry, 2026-04. Verfasst von Fidelis Nekesa Samita.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advancements in anticancer strategies such as radiotherapy, surgery, chemotherapy, and immunotherapy, cancer continues to be a global health burden. There were an estimated 20 million new cancer cases and 9.7 million deaths in 2022 with lung cancer leading in incidence and mortality. It ranks as the second most prevalent cause of death globally. Some of the challenges encountered in cancer treatment and management include toxicity of conventional treatments and multidrug resistance among others. There is therefore need for continued search for new drugs to counter these challenges and lessen the cancer burden. Plants are a potential source of compounds that can be developed into new anticancer agents. Bisbenylisoquinoline (BBIQ) alkaloids from plants belonging to the family Menispermaceae are a good example of compounds that have been shown to possess anticancer activity. The genus Triclisia belongs to this family. The plants in this genus have found use in traditional medicine where they are used in the management and treatment of many conditions and ailments including cancer. The main purpose of this review is to highlight the anticancer potential of BBIQ alkaloids from plants in this genus. Information was collected from scientific databases and relevant books. A literature survey revealed that there are five species in the genus Triclisia from which a total of 24 BBIQ alkaloids have been isolated. These are: Triclisia patens Oliv, T. dictyophylla Diels, T. gilletii DeWild, T. subcordata Oliv. and T. sacleuxii (Pierre) Diels. Phaeanthine, 1,2-dehydroapateline, tetrandrine, cycleanine, fangchinoline, aromoline, pycmanilline and cocsuline are some of the BBIQ alkaloids from these plants that are reported to possess anticancer properties. Some of the compounds like tetrandrine and fangchinoline have been extensively studied while others remain unexplored. The BBIQ alkaloids that have shown promising activity in vitro and in vivo should be subjected to preclinical trials and possibly clinical trials to assess their safety and effectiveness. Combination therapy and structural modifications are also areas that need more focus. The unexplored alkaloids should be studied to discover their anticancer potential. All these will help reduce the relatively high morbidity and mortality associated with cancer globally.

Zitieren

APA

Samita, F. N. (2026). Bisbenzylisoquinoline Alkaloids From Genus Triclisia As Potential Anticancer Agents: A Review. IOSR Journal of Applied Chemistry, 19(4), 18-27. https://doi.org/10.9790/5736-1904011827

Vancouver

Samita FN. Bisbenzylisoquinoline Alkaloids From Genus Triclisia As Potential Anticancer Agents: A Review. IOSR Journal of Applied Chemistry. 2026;19(4):18-27. doi:10.9790/5736-1904011827

BibTeX
@article{Samita2026,
  author = {Samita, Fidelis Nekesa},
  title = {Bisbenzylisoquinoline Alkaloids From Genus Triclisia As Potential Anticancer Agents: A Review},
  journal = {IOSR Journal of Applied Chemistry},
  year = {2026},
  volume = {19},
  number = {4},
  pages = {18--27},
  doi = {10.9790/5736-1904011827}
}
Kostenlos starten →